Localized extremity soft tissue sarcoma: an analysis of factors affecting survival.

The management of extremity soft tissue sarcoma is undergoing rapid change as new techniques of adjuvant treatment are developed. Critical assessment of these advances requires a fundamental understanding of the natural course of this disease. In an effort to define important prognostic factors, this review of 423 adults with localized extremity soft tissue sarcomas, treated at one institution (1968 to 1978), was undertaken. The effect of the following variables on survival was examined: patient factors, ie, age, sex, symptoms, and status at presentation; tumor factors, ie, site, size, depth, bone or neurovascular invasion, histogenesis, grade, and nodal status; and treatment factors, ie, biopsy technique, type of operation, surgical margins, adjuvant treatment, and subsequent local treatment failure. Patient factors with an adverse impact on survival included age greater than 53 and the presence of local symptoms. High tumor grade, positive regional nodes, histology other than liposarcoma, fibrosarcoma or malignant fibrohistiocytoma, invasion of vital structures, proximal site, deep location, and size greater than 10 cm were also poor prognosticators. Treatment factors correlating with optimal survival included limb sparing surgery, adequate margins, biopsy with delayed definitive resection, and absence of subsequent local failure. Patients treated by amputation had a greater proportion of risk factors than patients treated with limb-sparing surgery (LSS). When the data were subjected to multivariate analysis, the following variables emerged as independent predictors of poor outcome: local symptoms, age greater than 53, high grade, proximal site, size greater than 10 cm, positive regional nodes, surgery by amputation, and inadequate margins. These factors are now to be evaluated in our prospective study based on 600 patients with soft tissue sarcoma of all sites admitted to our institution in the last 3 years. These factors should be considered as important stratifications in prospective trials.

[1]  E. Mindell,et al.  The principles and technique of resection of soft parts for sarcoma. , 1958, Surgery.

[2]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[3]  F. Chu,et al.  The Problem of Local Recurrence after Treatment of Soft Tissue Sarcoma , 1968, Annals of surgery.

[4]  D. Cox.  Regression Models and Life-Tables , 1972 .

[5]  J. Fortner,et al.  Surgical Treatment of 297 Soft Tissue Sarcomas of the Lower Extremity , 1975, Annals of surgery.

[6]  H. Suit,et al.  Sarcoma of soft tissue: Clinical and histopathologic parameters and response to treatment , 1975, Cancer.

[7]  W. Enneking,et al.  The management of soft-tissue sarcomas of the extremities. , 1976, The Journal of bone and joint surgery. American volume.

[8]  H. Suit,et al.  A clinical and pathological staging system for soft tissue sarcomas , 1977, Cancer.

[9]  S. Hajdu.  Pathology of Soft Tissue Tumors , 1979 .

[10]  H. Sears,et al.  Analysis of Staging and Management of Patients with Sarcoma: A Ten‐year Experience , 1980, Annals of surgery.

[11]  D. Morton,et al.  Is Amputation Necessary for Sarcomas? A Seven‐Year Experience with Limb Salvage , 1980, Annals of surgery.

[12]  P. Sordillo,et al.  Adjuvant chemotherapy of soft‐part sarcomas with ALOMAD (S4) , 1981, Journal of surgical oncology.

[13]  R. Lindberg,et al.  Conservative surgery and postoperative radiotherapy in 300 adults with soft‐tissue sarcomas , 1981, Cancer.

[14]  C. Karakousis,et al.  The surgical treatment and outcome of soft-tissue sarcoma. , 1981, Archives of surgery.

[15]  S. Rosenberg,et al.  Perspectives on the role of surgery and radiation therapy in the treatment of soft tissue sarcomas of the extremities. , 1981, Seminars in oncology.

[16]  W. Wood,et al.  Preoperative radiation therapy for sarcoma of soft tissue , 1981, Cancer.

[17]  J. Tepper,et al.  The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. , 1982, Annals of surgery.

[18]  B. Stener,et al.  A multivariate analysis of the prognosis after surgical treatment of malignant soft‐tissue tumors , 1982, Cancer.

[19]  B. Hilaris,et al.  Control of locally advanced extremity soft tissue sarcomas by function‐saving resection and brachytherapy , 1984, Cancer.

[20]  W. Wood,et al.  Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  R. Gelber,et al.  Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials. , 1985, Cancer treatment reports.

[22]  S. Rosenberg,et al.  High‐grade soft tissue sarcomas of the extremities , 1986, Cancer.

[23]  J. Godbold,et al.  Localized, operable soft tissue sarcoma of the lower extremity. , 1986, Archives of surgery.

[24]  W. T. Miller,et al.  Recurrence‐free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors , 1986, Cancer.

[25]  S. Hajdu,et al.  Differential Diagnosis of Soft Tissue and Bone Tumors , 1986 .

[26]  J. Godbold,et al.  Localized Operable Soft Tissue Sarcoma of the Upper Extremity: Presentation, Management, and Factors Affecting Local Recurrence in 108 Patients , 1987, Annals of surgery.